CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity
April C. Watt(The University of Melbourne), Shom Goel(Dana-Farber Cancer Institute), Paloma Cejas(Dana-Farber Cancer Institute), Joan Montero(United Biscuits (United Kingdom)), Clifford A. Meyer(Dana-Farber Cancer Institute), Omer Gilan(The University of Melbourne), Anthony Letai(Dana-Farber Cancer Institute), Otto Metzger(Dana-Farber Cancer Institute), Rhiannon Coulson(The University of Melbourne), Klothilda Lim(Dana-Farber Cancer Institute), Claudia Giambartolomei(University College London), Ian E. Krop(Yale Cancer Center), Myles Brown(Harvard University), X. Cynthia(Washington University in St. Louis), Xintao Qiu(Dana-Farber Cancer Institute), Enid Y.N. Lam(The University of Melbourne), Jean J. Zhao(Harvard University), Raga Vadhi(Dana-Farber Cancer Institute), Len Taing(Dana-Farber Cancer Institute), Matthew J. Ellis(Guardant (United States)), Bogdan Paşaniuc(Translational Therapeutics (United States)), Haley BrinJones(Dana-Farber Cancer Institute), Mark A. Dawson(The University of Melbourne), Nikolas Kesten(Dana-Farber Cancer Institute), Henry W. Long(Dana-Farber Cancer Institute), Eric P. Winer(University of Vermont), Molly J. DeCristo(Dana-Farber Cancer Institute), Charles C. Bell(The University of Melbourne), Matthew L. Freedman(Brigham and Women's Hospital), Veerle W. Daniëls(Dana-Farber Cancer Institute), Keegan Korthauer(Harvard University), Ji-Heui Seo(Dana-Farber Cancer Institute), Alba Font‐Tello(Dana-Farber Cancer Institute)
Cited by 110
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Integrative approaches for large-scale transcriptome-wide association studies
|Nature Genetics|2016|2.7k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k